Publication Name	World Journal of Gastroenterology
Manuscript ID	24812
Country	Spain

Received	2016-02-10 15:12
Peer-Review Started	2016-02-10 19:50
To Make the First Decision	2016-03-21 09:20
Return for Revision	2016-03-21 13:53
Revised	2016-04-10 19:56
Second Decision	2016-04-26 12:04
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2016-05-04 16:47
Articles in Press	2016-05-04 16:47
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-05-18 16:01
Publish the Manuscript Online	2016-06-02 15:26

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Meta-Analysis
Article Title	Hepatitis C virus genotype 3: Meta-analysis on sustained virologic response rates with currently available treatment options
Manuscript Source	Invited Manuscript
All Author List	Javier Ampuero, K Rajender Reddy and Manuel Romero-Gomez
Funding Agency and Grant Number
Corresponding Author	Manuel Romero-Gomez, Full Professor, Head of Inter-Centre Unit of Digestive Diseases, Virgen Macarena, Virgen del Rocío University Hospitals, Av. Manuel Siurot, s/n, 41013 Sevilla, Spain. mromerogomez@us.es
Key Words	Hepatitis C; Genotype 3; Sofosbuvir; Daclatasvir; Ledipasvir
Core Tip	The landscape of therapy for hepatitis C virus infection is changing rapidly. In genotype 3, the improvement in SVR rates has not been hugely spectacular, being considered the most difficult genotype to treat and representing a major challenge. The advent of direct acting antivirals has not solved all questions about the treatment, while challenges remain such as the use of RBV, the duration of PEG-IFN-free treatment and whether PEG-IFN still plays an important role. These questions are difficult to elucidate with the current data because of the small number of patients included in clinical trials (particularly, those with cirrhosis) and their different designs.
Publish Date	2016-06-02 15:26
Citation	Ampuero J, Reddy KR, Romero-Gomez M. Hepatitis C virus genotype 3: Meta-analysis on sustained virologic response rates with currently available treatment options. World J Gastroenterol 2016; 22(22): 5285-5292
URL	http://www.wjgnet.com/1007-9327/full/v22/i22/5285.htm
DOI	http://dx.doi.org/10.3748/wjg.v22.i22.5285

Full Article (PDF)	WJG-22-5285.pdf
Full Article (Word)	WJG-22-5285.doc
Manuscript File	24812-Review.docx
Answering Reviewers	24812-Answering reviewers.pdf
Audio Core Tip	24812-Audio core tip.m4a
Biostatistics Review Certificate	24812-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	24812-Conflict-of-interest statement.pdf
Copyright License Agreement	24812-Copyright assignment.pdf
Peer-review Report	24812-Peer-review(s).pdf
Scientific Misconduct Check	24812-Scientific misconduct check.pdf
Scientific Editor Work List	24812-Scientific editor work list.pdf